Home > Articles > Published articles > MYC's Fine Line Between B Cell Development and Malignancy |
Date: | 2020 |
Abstract: | The transcription factor MYC is transiently expressed during B lymphocyte development, and its correct modulation is essential in defined developmental transitions. Although temporary downregulation of MYC is essential at specific points, basal levels of expression are maintained, and its protein levels are not completely silenced until the B cell becomes fully differentiated into a plasma cell or a memory B cell. MYC has been described as a proto-oncogene that is closely involved in many cancers, including leukemia and lymphoma. Aberrant expression of MYC protein in these hematological malignancies results in an uncontrolled rate of proliferation and, thereby, a blockade of the differentiation process. MYC is not activated by mutations in the coding sequence, and, as reviewed here, its overexpression in leukemia and lymphoma is mainly caused by gene amplification, chromosomal translocations, and aberrant regulation of its transcription. This review provides a thorough overview of the role of MYC in the developmental steps of B cells, and of how it performs its essential function in an oncogenic context, highlighting the importance of appropriate MYC regulation circuitry. |
Grants: | Ministerio de Ciencia e Innovación SAF2017-87990-R Ministerio de Ciencia e Innovación EUR2019-103835 Ministerio de Ciencia e Innovación FJCI-2017-32430 Agencia Estatal de Investigación PRE2018-083183 |
Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Language: | Anglès |
Document: | Article ; recerca ; Versió publicada |
Subject: | MYC ; B cell development ; Leukemia ; Lymphoma |
Published in: | Cells, Vol. 9 Núm. 2 (24 2020) , ISSN 2073-4409 |
24 p, 1.1 MB |